APA

da Costa W. H., Fares A. F., Bezerra S. M., Morini M. A., de Toledo Benigno L. A., Clavijo D. A., Fornazieri L., Rocha M. M., da Cunha I. W. & de Cassio Zequi S. (20190305). Loss of BAP1 expression in metastatic tumor tissue is an event of poor prognosis in patients with metastatic clear cell renal cell carcinoma. : Urologic oncology.

Chicago

da Costa Walter Henriques, Fares Aline Fusco, Bezerra Stephania M, Morini Mariana A, de Toledo Benigno Ligia Alencar, Clavijo Diego Abreu, Fornazieri Lucas, Rocha Maurício Murce, da Cunha Isabela Werneck and de Cassio Zequi Stenio. 20190305. Loss of BAP1 expression in metastatic tumor tissue is an event of poor prognosis in patients with metastatic clear cell renal cell carcinoma. : Urologic oncology.

Harvard

da Costa W. H., Fares A. F., Bezerra S. M., Morini M. A., de Toledo Benigno L. A., Clavijo D. A., Fornazieri L., Rocha M. M., da Cunha I. W. and de Cassio Zequi S. (20190305). Loss of BAP1 expression in metastatic tumor tissue is an event of poor prognosis in patients with metastatic clear cell renal cell carcinoma. : Urologic oncology.

MLA

da Costa Walter Henriques, Fares Aline Fusco, Bezerra Stephania M, Morini Mariana A, de Toledo Benigno Ligia Alencar, Clavijo Diego Abreu, Fornazieri Lucas, Rocha Maurício Murce, da Cunha Isabela Werneck and de Cassio Zequi Stenio. Loss of BAP1 expression in metastatic tumor tissue is an event of poor prognosis in patients with metastatic clear cell renal cell carcinoma. : Urologic oncology. 20190305.